National Storage Mechanism | Additional information
RNS Number : 6222D
Societe Generale SA
30 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

               Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

29/06/2021

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

1,876,040

1.45

2,539

0.00

(2) Derivatives (other than options)

141

0.00

599,709

0.46

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*2,150,055

*1.67

602,248

0.47

                               

* Include the holding of 273,874 shares on borrow products

               

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

30

232.44

Purchase

40

232.44

Purchase

30

232.44

Purchase

1

231.54

Purchase

2

231.54

Purchase

103

232.19

Sale

100

233.33

Sale

8

232.9

Sale

92

232.9

Sale

5

233.57

Sale

95

233.57

Sale

100

232.71

Sale

50

232.57

Sale

50

232.57

Sale

100

232.55

Sale

100

233.33

Sale

10

232.61

Sale

11

232.23

Sale

8

232.93

Sale

92

232.93

Sale

64

233.46

Sale

36

233.46

Sale

100

233.73

Sale

55

233.22

Sale

45

233.22

Sale

79

233.34

Sale

21

233.34

Sale

100

233.35

Sale

91

233.15

Sale

9

233.15

Sale

31

232.62

Sale

32

232.62

Sale

37

232.62

Sale

93

233.18

Sale

7

233.18

Sale

100

233.04

Sale

100

232.19

Sale

64

232.19

Sale

5

232.62

Sale

6

232.62

Sale

7

232.32

Sale

5

232.65

Sale

5

232.36

Sale

5

232.49

Sale

4

232.49

Sale

5

232.5

Sale

5

232.62

Sale

5

232.9

Sale

5

232.9

Sale

6

232.55

Sale

9

232.24

Sale

14

232.24

Sale

5

232.59

Sale

5

232.6

Sale

5

232.49

Sale

6

232.55

Sale

7

232.52

Sale

5

232.65

Sale

5

232.49

Sale

5

232.5

Sale

5

232.63

Sale

5

232.88

Sale

5

232.77

Sale

5

232.83

Sale

5

232.72

Sale

5

232.62

Sale

5

232.73

Sale

5

232.55

Sale

6

232.55

Sale

5

232.63

Sale

5

232.6

Sale

5

232.62

Sale

5

232.72

Sale

5

232.83

Sale

5

232.8

Sale

7

232.59

Sale

5

232.71

Sale

5

232.71

Sale

5

232.6

Sale

5

232.74

Sale

5

232.62

Sale

5

232.52

Sale

6

232.42

Sale

5

232.36

Sale

6

232.76

Sale

5

233.01

Sale

7

232.3

Sale

5

232.99

Sale

7

232.19

Sale

5

232.88

Sale

5

232.26

Sale

5

232.45

Sale

5

232.76

Sale

5

232.42

Sale

6

232.76

Sale

5

232.47

Sale

5

232.56

Sale

6

232.26

Sale

5

232.26

Sale

5

232.76

Sale

5

232.84

Sale

5

232.44

Sale

5

232.44

Sale

5

232.57

Sale

5

232.81

Sale

6

232.81

Sale

1

232.49

Sale

5

232.84

Sale

5

232.62

Sale

5

232.81

Sale

5

232.69

Sale

6

232.36

Sale

5

232.36

Sale

5

232.58

Sale

5

232.49

Sale

5

232.58

Total Purchases

206

 

Total Sales

2,303

 

 

Derivatives transactions (other than options transactions)

 

Product name,
e.g. CFD

Nature of transaction
(Note 6)

Number of relevant securities
(Note 7)

Price per unit USD
(Note 5)

CFD

Decreased Short

418

232.5740239

 

(b)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            No

 

Date of disclosure

30/06/2021

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEFIFSRRAIIVIL